• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷胱甘肽S-转移酶基因多态性与α-突触核蛋白A53T突变型帕金森病的发病年龄

Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.

作者信息

Golbe Lawrence I, Di Iorio Giuseppe, Markopoulou Katerina, Athanassiadou Aglaia, Papapetropoulos Spiridon, Watts Ray L, Vance Jeffery M, Bonifati Vincenzo, Williams Tanishia A, Spychala John R, Stenroos E Scot, Johnson Williams G

机构信息

Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

出版信息

Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):254-8. doi: 10.1002/ajmg.b.30450.

DOI:10.1002/ajmg.b.30450
PMID:17034008
Abstract

Monogenic forms of Parkinson's disease (PD) provide an opportunity to examine mechanisms underlying phenotypic variation. Glutathione S-transferase (GST) has detoxification and antioxidative functions. To screen genetic variations in GST for an effect on the onset age (OA) of PD, we typed seven common genetic polymorphisms in five GST isoenzymes, M1, M3, P1, T1, and Z1, in 36 affected individuals of Italian or Greek origin with the alpha-synuclein A53T (PARK1) mutation. Mean OA was 45.2 years with a wide SD of 11.03 years, similar to that of idiopathic PD. Our allelic analysis showed that the subjects homozygous for the GSTP1 G-for-A nucleotide substitution at position 313 had a mean OA acceleration of 15.2 years (31.3 +/- 7.09 years, n = 3 vs. 46.5 +/- 10.50 years, n = 33, P = 0.020). The GSTP1 C341T substitution was associated with a 9.7-year acceleration of OA, but the significance was borderline (36.4 +/- 8.35 years vs. 46.7 +/- 10.85 years, P = 0.0519). After correction for the five genes examined, both results lose statistical significance. Nevertheless, our results suggest that further investigation in GSTP1 variants and PD pathogenesis is warranted in sporadic PD and that a search for toxins that accelerate PD OA should pay particular attention to GST-P1 substrates.

摘要

帕金森病(PD)的单基因形式为研究表型变异背后的机制提供了契机。谷胱甘肽S-转移酶(GST)具有解毒和抗氧化功能。为了筛查GST基因变异对PD发病年龄(OA)的影响,我们对36名具有意大利或希腊血统且携带α-突触核蛋白A53T(PARK1)突变的患病个体,检测了5种GST同工酶(M1、M3、P1、T1和Z1)中的7种常见基因多态性。平均OA为45.2岁,标准差为11.03岁,与特发性PD相似。我们的等位基因分析显示,在313位核苷酸处GSTP1的G被A取代的纯合子受试者,平均OA加速了15.2岁(31.3±7.09岁,n = 3,对比46.5±10.50岁,n = 33,P = 0.020)。GSTP1 C341T取代与OA加速9.7岁相关,但显著性接近临界值(36.4±8.35岁对比46.7±10.85岁,P = 0.0519)。在对所检测的5个基因进行校正后,两个结果均失去统计学意义。尽管如此,我们的结果表明,对于散发性PD,有必要进一步研究GSTP1变异与PD发病机制,并且在寻找加速PD OA的毒素时,应特别关注GST-P1底物。

相似文献

1
Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.谷胱甘肽S-转移酶基因多态性与α-突触核蛋白A53T突变型帕金森病的发病年龄
Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):254-8. doi: 10.1002/ajmg.b.30450.
2
Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.帕金森病中谷胱甘肽S-转移酶M1、P1、T1和Z1基因多态性与吸烟相互作用的病例对照研究
Neurosci Lett. 2004 Aug 19;366(3):326-31. doi: 10.1016/j.neulet.2004.05.061.
3
Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.谷胱甘肽-S-转移酶P1基因中A313G多态性(GSTP1*B)与散发性帕金森病的关联
Eur J Neurol. 2007 Feb;14(2):156-61. doi: 10.1111/j.1468-1331.2006.01590.x.
4
Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease.谷胱甘肽 S-转移酶 M1、T1 和 P1 基因多态性与帕金森病
Neurosci Lett. 2003 Jan 30;337(1):5-8. doi: 10.1016/s0304-3940(02)01286-7.
5
Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.日本散发性帕金森病患者中α-突触核蛋白基因风险单倍型的鉴定。
Mov Disord. 2006 Dec;21(12):2157-64. doi: 10.1002/mds.21142.
6
Glutathione S-transferase polymorphism in Parkinson's disease.帕金森病中的谷胱甘肽S-转移酶多态性
J Neural Transm (Vienna). 2000;107(3):331-4. doi: 10.1007/s007020050027.
7
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.希腊人群中家族性和早发性帕金森病的基因评估
Eur J Neurol. 2014 Jul;21(7):963-8. doi: 10.1111/ene.12315. Epub 2013 Dec 7.
8
[The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].[α-突触核蛋白基因微卫星多态性与晚发性散发性帕金森病易感性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Aug;21(4):339-41.
9
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer.谷胱甘肽S-转移酶M1、P1和T1基因多态性与早发性前列腺癌的关系。
Pharmacogenetics. 2001 Jun;11(4):325-30. doi: 10.1097/00008571-200106000-00007.
10
GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population.GST 多态性、与吸烟和农药使用的相互作用以及日本人群帕金森病的风险。
Parkinsonism Relat Disord. 2010 Aug;16(7):447-52. doi: 10.1016/j.parkreldis.2010.04.009. Epub 2010 May 15.

引用本文的文献

1
In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid.体外抑制谷胱甘肽-S-转移酶的多巴胺及其代谢物,3,4-二羟基苯乙酮和 3,4-二羟基苯乙酸。
Neurotoxicology. 2021 Sep;86:85-93. doi: 10.1016/j.neuro.2021.07.005. Epub 2021 Jul 24.
2
Glutathione metabolism and Parkinson's disease.谷胱甘肽代谢与帕金森病。
Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8.
3
GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death.
谷胱甘肽S-转移酶P1,一种由富含亮氨酸重复激酶2(LRRK2)的G2019S突变体诱导神经元细胞死亡的新型下游调节因子。
Front Biosci (Elite Ed). 2012 Jun 1;4(7):2365-77. doi: 10.2741/e548.
4
Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.帕金森病患者血液中 MPP+ 诱导的氧化应激后谷胱甘肽 S-转移酶 pi 表达的改变。
Parkinsonism Relat Disord. 2011 Dec;17(10):765-8. doi: 10.1016/j.parkreldis.2011.06.026. Epub 2011 Aug 12.
5
Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.鉴定谷胱甘肽S-转移酶π为参与帕金森病进展的一种蛋白质。
Am J Pathol. 2009 Jul;175(1):54-65. doi: 10.2353/ajpath.2009.081019. Epub 2009 Jun 4.
6
GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.谷胱甘肽S转移酶π(GSTpi)在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的C57BL/6小鼠中脑和纹状体多巴胺能神经变性中的表达
J Mol Neurosci. 2009 Jun;38(2):114-27. doi: 10.1007/s12031-008-9141-z. Epub 2008 Sep 16.